Oracle (NYSE:ORCL) Downgraded by Weiss Ratings to Hold (C+)

Key Points

• Oracle has been downgraded by Weiss Ratings from a "buy" to a "hold" rating, reflecting recent concerns about its stock performance.
• Despite the downgrade, Oracle's stock has a mixed consensus among analysts, with three "Strong Buy," twenty-six "Buy," and two "Sell" ratings, along with a target price averaging $323.69.
• Insider trading activity includes significant stock sales by company executives, indicating potential changes in management confidence or strategy.

Oracle (NYSE:ORCL - Get Free Report) was downgraded by Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating in a research report issued on Saturday,Weiss Ratings reports.

Other research analysts have also recently issued reports about the company. Rothschild & Co Redburn assumed coverage on Oracle in a research note on Thursday, September 25th. They set a "sell" rating and a $175.00 target price for the company. Cantor Fitzgerald boosted their target price on Oracle from $271.00 to $400.00 and gave the company an "overweight" rating in a report on Wednesday, September 10th. UBS Group boosted their target price on Oracle from $360.00 to $380.00 and gave the company a "buy" rating in a report on Friday, October 17th. Baird R W raised Oracle to a "strong-buy" rating in a report on Wednesday, October 8th. Finally, Mizuho boosted their target price on Oracle from $300.00 to $350.00 and gave the company an "outperform" rating in a report on Wednesday, September 10th. Three analysts have rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $323.69.

Oracle Price Performance

ORCL traded up $3.38 during trading on Friday, hitting $283.45. The company's stock had a trading volume of 13,172,739 shares, compared to its average volume of 22,826,008. Oracle has a twelve month low of $118.86 and a twelve month high of $345.72. The firm has a market capitalization of $808.05 billion, a price-to-earnings ratio of 65.61, a P/E/G ratio of 3.04 and a beta of 1.53. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 3.33. The business's fifty day simple moving average is $274.59 and its 200 day simple moving average is $221.04.

Oracle (NYSE:ORCL - Get Free Report) last posted its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.48 by ($0.01). The business had revenue of $14.93 billion for the quarter, compared to analyst estimates of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.Oracle's revenue was up 12.2% compared to the same quarter last year. During the same period last year, the business earned $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, equities research analysts forecast that Oracle will post 5 EPS for the current fiscal year.

Insider Activity at Oracle

In other Oracle news, EVP Stuart Levey sold 19,758 shares of the business's stock in a transaction that occurred on Friday, October 10th. The stock was sold at an average price of $300.00, for a total transaction of $5,927,400.00. Following the transaction, the executive vice president owned 18,429 shares in the company, valued at approximately $5,528,700. The trade was a 51.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Michael D. Sicilia sold 33,845 shares of the business's stock in a transaction that occurred on Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total value of $10,869,660.20. Following the transaction, the insider owned 132,656 shares in the company, valued at $42,603,800.96. The trade was a 20.33% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 170,769 shares of company stock worth $50,297,667 in the last three months. 40.90% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Oracle

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Norges Bank acquired a new stake in shares of Oracle in the 2nd quarter worth approximately $4,275,378,000. Nuveen LLC acquired a new stake in shares of Oracle in the 1st quarter worth approximately $732,692,000. Vanguard Group Inc. grew its holdings in shares of Oracle by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider's stock worth $22,498,982,000 after acquiring an additional 3,513,464 shares during the period. Kingstone Capital Partners Texas LLC acquired a new stake in shares of Oracle in the 2nd quarter worth approximately $731,512,000. Finally, Invesco Ltd. grew its holdings in shares of Oracle by 42.1% in the 2nd quarter. Invesco Ltd. now owns 8,839,166 shares of the enterprise software provider's stock worth $1,932,507,000 after acquiring an additional 2,619,722 shares during the period. Institutional investors and hedge funds own 42.44% of the company's stock.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.